NF-κB and IRF pathways: cross-regulation on target genes promoter level | BMC Genomics | Full Text
Crosstalk between Fas and S1P1 signaling via NF-kB in osteoclasts controls bone destruction in the TMJ due to rheumatoid arthritis - ScienceDirect
Cells | Free Full-Text | Hypoxia Induced NF-κB
Frontiers | NF-κB and its crosstalk with endoplasmic reticulum stress in atherosclerosis
IJMS | Free Full-Text | NFkappaB is a Key Player in the Crosstalk between Inflammation and Cardiovascular Diseases
KEGG PATHWAY: hsa04064
Crosstalk between NF-κB and JAK/STAT as well as between SYK,TLR/NF-κB... | Download Scientific Diagram
The complexity of NF-κB signaling in inflammation and cancer | Molecular Cancer | Full Text
Crosstalk in NF-κB signaling pathways | Nature Immunology
NF-κB: blending metabolism, immunity, and inflammation: Trends in Immunology
NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches - ScienceDirect
Frontiers | What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion?
Crosstalk between the Nrf2 and NF-κB pathways. Oxidative stress... | Download Scientific Diagram
Crosstalk in NF-κB signaling pathways | Nature Immunology
Pathways: NF-kappaB Signaling | www.antibodies-online.com
NF-κB signaling and crosstalk during carcinogenesis
IJMS | Free Full-Text | NF-κB and Its Role in Checkpoint Control
Frontiers | An NFκB Activity Calculator to Delineate Signaling Crosstalk: Type I and II Interferons Enhance NFκB via Distinct Mechanisms
The complexity of NF-κB signaling in inflammation and cancer | Molecular Cancer | Full Text
NF-kappa B signaling pathway - Cusabio
NF-κB-Induced IL-6 Ensures STAT3 Activation and Tumor Aggressiveness in Glioblastoma | PLOS ONE
IJMS | Free Full-Text | Modulation of Nrf2 and NF-κB Signaling Pathways by Naturally Occurring Compounds in Relation to Cancer Prevention and Therapy. Are Combinations Better Than Single Compounds?
Cancers | Free Full-Text | NF-κB/Rel Transcription Factors in Pancreatic Cancer: Focusing on RelA, c-Rel, and RelB
